Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 9:6:1397446.
doi: 10.3389/frph.2024.1397446. eCollection 2024.

Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus

Saghar Salehpour  1 , Ashraf Aleyasin  2 , Ashraf Moini  3   4   5 , Nezhat Mousavifar  6 , Nasresfahani Mohammadhossein  7 , Sedighe Abdollahi Fard  8 , Sanuiefarimani Marzie  9 , Mahboubeh Mohammadzadeh  10 , Robert Fischer  11
Affiliations

Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus

Saghar Salehpour et al. Front Reprod Health. .

Abstract

Introduction: Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity.

Methods: Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements.

Results: Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3') obtained an 83% agreement.

Discussion: The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies.

Keywords: ART; Delphi consensus; Iran; LH supplementation; expert; ovarian stimulation.

PubMed Disclaimer

Conflict of interest statement

All authors had received honoraria from Merck for participating in this consensus.

Figures

Figure 1
Figure 1
Consensus development methodology.
Figure 2
Figure 2
Level of agreement/disagreement on each statement.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Duggavathi R, Murphy BD. Development. Ovulation signals. Science. (2009) 324(5929):890–1. 10.1126/science.1174130 - DOI - PubMed
    1. Hall JE. Chapter 7—neuroendocrine control of the menstrual cycle. In: Strauss JF, Barbieri RL, editors. Yen and Jaffe’s Reproductive Endocrinology, Eighth ed. Philadelphia: Elsevier; 2019. p. 149–66.e5.
    1. Freis A, Germeyer A, Jauckus J, Capp E, Strowitzki T, Zorn M, et al. Endometrial expression of receptivity markers subject to ovulation induction agents. Arch Gynecol Obstet. (2019) 300(6):1741–50. 10.1007/s00404-019-05346-y - DOI - PubMed
    1. Bosch E, Alviggi C, Lispi M, Conforti A, Hanyaloglu AC, Chuderland D, et al. Reduced FSH and LH action: implications for medically assisted reproduction. Hum Reprod. (2021) 36(6):1469–80. 10.1093/humrep/deab065 - DOI - PMC - PubMed
    1. Casarini L, Santi D, Brigante G, Simoni M. Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG. Endocr Rev. (2018) 39(5):549–92. 10.1210/er.2018-00065 - DOI - PubMed

LinkOut - more resources